REHMANN CAPITAL ADVISORY GROUP – Novo Nordisk A/S Transaction History
REHMANN CAPITAL ADVISORY GROUP portfolio value:
$914,105
portfolio value
REHMANN CAPITAL ADVISORY GROUP quarter portfolio value change:
-10.59%
quarter
Novo Nordisk A/S 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.83% | -171 shares | -127.36K | $99.63 | 9.17K |
| Q2 2022 | share | Increase | +4.69% | 419 shares | 47.61K | $111.43 | 9.34K |
| Q1 2022 | share | Increase | +7.26% | 604 shares | 61.61K | $111.05 | 8.92K |
| Q4 2021 | share | Decrease | -5.73% | -506 shares | 83.84K | $111.45 | 8.32K |
| Q3 2021 | share | Decrease | -0.25% | -22 shares | 104.61K | $96.01 | 8.82K |
| Q2 2021 | share | Increase | +0.64% | 56 shares | 150.81K | $83.32 | 8.85K |
| Q1 2021 | share | Increase | +0.13% | 11 shares | -20.60K | $67.06 | 8.79K |
| Q4 2020 | share | Decrease | -0.39% | -34 shares | 1.32K | $68.52 | 8.78K |
| Q3 2020 | share | Decrease | -1.67% | -150 shares | 24.99K | $68.1 | 8.81K |
| Q2 2020 | share | Decrease | -5.33% | -505 shares | 16.96K | $63.73 | 8.96K |
| Q1 2020 | share | Increase | +698.74% | 8.28K shares | 508.98K | $58.59 | 9.47K |
| Q3 2019 | share | Decrease | -0.34% | -4 shares | 548 | $49.63 | 1.18K |
| Q2 2019 | share | Increase | +27.27% | 255 shares | 11.85K | $48.57 | 1.19K |
| Q1 2019 | share | Increase | +15.72% | 127 shares | 11.68K | $49.78 | 935 |
| Q4 2018 | share | Increase | +2.28% | 18 shares | -16 | $43.17 | 808 |
| Q3 2018 | share | Decrease | -0.13% | -1 shares | 783 | $44.17 | 790 |
| Q2 2018 | share | Decrease | -27.30% | -297 shares | -17.53K | $43.22 | 791 |
| Q1 2018 | share | Increase | 0.00% | 1.08K shares | 54K | $46.15 | 1.08K |